Barricaid logo

Intrinsic Therapeutics, Inc.


Barricaid Stock

Barricade is a clinical-stage medical device company focused on developing minimally invasive solutions for chronic disc-related back pain. Its flagship product, the AnulusSEAL™, is designed to treat lumbar disc herniations by sealing tears in the outer layer of the spinal disc (the annulus fibrosis) to contain disc material, alleviate nerve compression, and reduce pain.

Management Team

Cary Hagan President and CEO
Greg Lambrecht Founder and Executive Director
Jacob Einhorn CTO
Oscar Yeh COO
Peter Pizzo CFO

Funding Information